An Embryonic Disaster?
By Isabel Oakeshott and Sarah-Kate Templeton,
The Sunday Times
| 03. 16. 2008
The government’s new fertility bill is under fire on religious, moral and even scientific grounds
When Liz Shipley was diagnosed with motor neurone disease (MND) it came as
little surprise. The 36-year-old from Newcastle had lost her mother to the
same condition when she was just three years old. Several other members of
her family, including her sister and uncle, had died or were suffering from
the muscle-wasting disease.
Ten years on and unable to walk, write or dress herself, she fears that her
two teenage children will also inherit the disease. Shipley does not expect
a cure in her lifetime but she backs controversial scientific research using
embryos that are part-human, part-animal, which could lead to a treatment
for her children if they are struck down.
“When you have an illness for which there is no cure, you have to investigate
every avenue,” said Shipley. “I do not want my children to be told in 20
years’ time that they have MND and there is still no cure. I believe the
answers will lie in stem cells of some kind. Hopefully this research will be
able to tell us why this is happening to...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...